Overview

Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

Status:
Withdrawn
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Treatment with Ranibizumab of the residual diabetic edema in patients with failed response to Bevacizumab.
Phase:
Phase 2
Details
Lead Sponsor:
New England Retina Associates
Treatments:
Bevacizumab
Ranibizumab